The Venture Codex

Participated · Equity · Jul 2026

TidalSense develops an AI-powered diagnostic test, N-Tidal Diagnose, that captures a CO₂ waveform via a handheld device during normal breathing and analyzes it with AI models. The test requires patients to breathe into the device for around 75 seconds and TidalSense says its models have been trained on more than 2.5 million patient breaths. The company states that tests can be performed in under five minutes and that clinicians can see four to six patients an hour versus roughly one per hour with traditional spirometry. TidalSense says any healthcare professional can be trained to use the device in about 10 minutes without specialist qualifications. It launched the test on the NHS last year and plans to scale rollout across the NHS, expand into Europe and enter the US market. The company is led by CEO Dr. Ameera Patel and was founded in 2013.

Participated · Equity · Jul 2024

Recast provides an API-centric smart payment platform and a micro-payment wallet that help media owners maximise distribution, monetisation, and first-party data capture while offsetting subscription fatigue and churn. The product supports monetising video and livestreams and has evolved from a destination streaming service into an integrated fintech platform for media publishers. The company says its technology facilitates the sale of digital commodities anywhere on the internet and beyond its current offering. Recast plans to use the new funding to further develop its API platform and enhance its micro-payment wallet. The business emphasises quick revenue generation for media owners and seamless, affordable access to content for consumers. The company is based in Edinburgh and recently closed a new funding round.